The IDE approval marks a pivotal milestone for Aqua Medical, allowing the company to begin enrolling patients in the U.S. RESTORE-1 pilot trial and study PIMA's potential to deliver durable metabolic ...
Aqua Medical has received investigational device exemption (IDE) from the FDA for its ablation device aimed at treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback